Advocating at the global level to achieve cardiovascular health for everyone
Advocating for fiscal policies, including taxes on tobacco, alcohol and sugar-sweetened beverages, to help fund UHC.
Learn moreAir pollution is a significant risk factor for CVD and as such must urgently be addressed through research, education, and policy change.
Learn moreRHD is a preventable, treatable form of cardiovascular disease that affects over 33 million people around the world, chiefly in low-resource settings.
Learn moreAs smoking prevalence continues to climb in the developing world, we are mobilizing the CVD community in the fight against tobacco.
Learn moreWHF is the only organization representing the CVD community in Official Relations with the WHO, the global authority on public health policy.
Learn moreOur advocacy experts work closely with the UN, its agencies, and other international bodies to influence global policies, strategies and funding.
Learn moreThis Committee is composed of experts representing each WHO Region. It serves to inform and approve science-based policy proposals.
Learn moreThe TEG supports the development of WHF position papers, external statements, and internal policies to advance progress on global tobacco control.
Learn moreThe APEG guides the work of WHF in the area of air pollution and CVD, identifying areas for further research and prioritizing key advocacy objectives.
Learn moreThe Global Coalition for Circulatory Health brings together international, regional and national stakeholders in circulatory health.
Learn moreThis is a statement made at the 75th World Health Assembly (22-28 May 2022) on Agenda Item 14.1: Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases; Annex A: Draft implementation road map 2023–2030 for the global action plan for the prevention […]
This is a statement made at the 75th World Health Assembly (22-28 May 2022) on Agenda Item 16.2: Strengthening WHO preparedness for and response to health emergencies. Honourable Chair, Distinguished Delegates, People living with circulatory conditions are disproportionately impacted by the COVID-19 pandemic. The lack of attention to NCDs in the early stages of […]
Hypertension is the leading preventable risk factor for cardiovascular disease. It affects an estimated 1.3 billion worldwide, killing approximately 10 million people every year. Low and middle-income countries have seen a growing prevalence of hypertension in recent years, with many countries having to deal with the double burden of communicable and non-communicable diseases. In Sub-Saharan […]
Hypertension
This is a statement made at the 150th Executive Board Meeting of the World Health Organization on Agenda Item 15.3: WHO’s work in health emergencies Honourable Chair, Distinguished Delegates, People living with circulatory conditions are disproportionately impacted by the COVID-19 pandemic. The lack of attention to NCDs in the early stages of the pandemic impeded […]
We urge @WHO Member States to: 📊 Integrate #NCD and mental health indicators in health systems performance 🤝 Adopt… https://t.co/8yrN16ypkS
about 4 hours ago
RT @WHO: Day 5 of the 75th World Health Assembly #WHA75 will resume at 09h00 CEST. Follow live here https://t.co/tDliixgN6k Find today’s p…
about 4 hours ago
RT @RaniaAlMashat: Moderated by @Harvard’s @RifatAtun & opening remarks by @Novartis Marie-France Tschudin, special convo. on public-privat…
about 21 hours ago
RT @mqueiroga2: Durante o @wef, em Davos, participei de um debate com participação do pres. da @worldheartfed, do prof. Atun, de @Harvard,…
about 21 hours ago
RT @IAHPC: #WHA Thank you @worldheartfed for including #palliativecare in your Constituency statement on #NCDs gold ⭐️ 🌟 https://t.co/eBu…
about 21 hours ago